Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Pharmacopsychiatry|October 14, 2011
Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case reportS Unterecker, B Warrings, J Deckert, et al.Pharmacopsychiatry|September 4, 2015
Retrospective pilot study for analysis of antidepressant serum concentrations of citalopram and venlafaxine during inflammationG Hefner, M E E Shams, S Unterecker, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 21, 2012
Effects of gender and age on serum concentrations of antidepressants under naturalistic conditionsS Unterecker, P Riederer, F Proft, et al.Pharmacopsychiatry|March 20, 2012
The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditionsS Unterecker, C Hiemke, C Greiner, et al.Journal of Neural Transmission. Supplementum|November 7, 2007
Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practiceB Pfuhlmann, M Gerlach, R Burger, et al.Pharmacopsychiatry|October 9, 2014
SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcomeF Proft, J Kopf, D Olmes, et al.Translational Psychiatry|April 4, 2026
Momentary anxiety and autonomic responses during everyday social interactions among patients with depressionM Weiß, J Gutzeit, A Jachnik, et al.The British Journal of Psychiatry : the Journal of Mental Science|November 6, 2007
Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trialU Herwig, A J Fallgatter, J Höppner, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 12, 2021
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressantsC B Eap, G Gründer, P Baumann, et al.Pharmacopsychiatry|September 15, 2017
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.Pageof 1